Imatinib activity on Schistosoma mansoni

Imatinib, a drug used for treatment of human chronic myeloid leukaemia, due to its activity against protein kinases, has been also evaluated in vitro against Schistosoma mansoni showing high schistosomicidal activity. In the present experiments imatinib activity in vitro was confirmed at the doses o...

Full description

Bibliographic Details
Main Authors: Naftale Katz, Flavia Fernanda Bubulo Couto, Neusa Araujo
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2013-11-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000700850&lng=en&tlng=en
_version_ 1797756689997365248
author Naftale Katz
Flavia Fernanda Bubulo Couto
Neusa Araujo
author_facet Naftale Katz
Flavia Fernanda Bubulo Couto
Neusa Araujo
author_sort Naftale Katz
collection DOAJ
description Imatinib, a drug used for treatment of human chronic myeloid leukaemia, due to its activity against protein kinases, has been also evaluated in vitro against Schistosoma mansoni showing high schistosomicidal activity. In the present experiments imatinib activity in vitro was confirmed at the doses of 25 µM, 50 µM and 100 µM. The first drug activity observed with the lower dose was interruption of egg-laying and with the higher dosages was the death of the worms. In mice infected with S. mansoni no activity was found even with 1,000 mg/kg/day, 500 mg/kg/day, single oral dose or when administered for three consecutive days. This is another example of the difference of results related to in vitro and in vivo trials using S. mansoni worms.
first_indexed 2024-03-12T18:04:07Z
format Article
id doaj.art-1af8b63f380f46c6b1f9dad860356a50
institution Directory Open Access Journal
issn 1678-8060
language English
last_indexed 2024-03-12T18:04:07Z
publishDate 2013-11-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-1af8b63f380f46c6b1f9dad860356a502023-08-02T09:29:08ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz1678-80602013-11-01108785085310.1590/0074-0276130207S0074-02762013000700850Imatinib activity on Schistosoma mansoniNaftale KatzFlavia Fernanda Bubulo CoutoNeusa AraujoImatinib, a drug used for treatment of human chronic myeloid leukaemia, due to its activity against protein kinases, has been also evaluated in vitro against Schistosoma mansoni showing high schistosomicidal activity. In the present experiments imatinib activity in vitro was confirmed at the doses of 25 µM, 50 µM and 100 µM. The first drug activity observed with the lower dose was interruption of egg-laying and with the higher dosages was the death of the worms. In mice infected with S. mansoni no activity was found even with 1,000 mg/kg/day, 500 mg/kg/day, single oral dose or when administered for three consecutive days. This is another example of the difference of results related to in vitro and in vivo trials using S. mansoni worms.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000700850&lng=en&tlng=enschistosomiasischemotherapyimatinib
spellingShingle Naftale Katz
Flavia Fernanda Bubulo Couto
Neusa Araujo
Imatinib activity on Schistosoma mansoni
Memorias do Instituto Oswaldo Cruz
schistosomiasis
chemotherapy
imatinib
title Imatinib activity on Schistosoma mansoni
title_full Imatinib activity on Schistosoma mansoni
title_fullStr Imatinib activity on Schistosoma mansoni
title_full_unstemmed Imatinib activity on Schistosoma mansoni
title_short Imatinib activity on Schistosoma mansoni
title_sort imatinib activity on schistosoma mansoni
topic schistosomiasis
chemotherapy
imatinib
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000700850&lng=en&tlng=en
work_keys_str_mv AT naftalekatz imatinibactivityonschistosomamansoni
AT flaviafernandabubulocouto imatinibactivityonschistosomamansoni
AT neusaaraujo imatinibactivityonschistosomamansoni